Alecta Tjanstepension Omsesidigt boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 55.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 839,700 shares of the medical device company's stock after buying an additional 300,700 shares during the period. Alecta Tjanstepension Omsesidigt owned 0.42% of Cooper Companies worth $70,829,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Covestor Ltd boosted its holdings in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the last quarter. Shell Asset Management Co. grew its holdings in Cooper Companies by 15.5% during the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after buying an additional 127 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Cooper Companies by 16.7% during the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock worth $76,000 after acquiring an additional 129 shares in the last quarter. Axxcess Wealth Management LLC boosted its holdings in shares of Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after purchasing an additional 140 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC boosted its holdings in shares of Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after purchasing an additional 157 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Cooper Companies Trading Up 0.6%
Shares of NASDAQ:COO traded up $0.42 during midday trading on Thursday, reaching $73.80. The company's stock had a trading volume of 2,526,673 shares, compared to its average volume of 2,241,383. The firm has a market cap of $14.76 billion, a price-to-earnings ratio of 35.83, a price-to-earnings-growth ratio of 1.78 and a beta of 0.99. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38. The business has a 50 day moving average price of $73.60 and a 200 day moving average price of $81.71.
Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm's revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.85 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
Analyst Ratings Changes
Several equities analysts recently issued reports on COO shares. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $76.00 target price (down from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a report on Tuesday, June 17th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research note on Tuesday, June 17th. Finally, Mizuho reduced their price target on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. Three analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Cooper Companies currently has an average rating of "Moderate Buy" and an average target price of $96.73.
View Our Latest Research Report on COO
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles

Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.